iBio, Inc. (IBIO) Debt-to-equity % [USD] 2015 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
iBio, Inc. quarterly Debt-to-equity history and growth rate from 2015 to 2024.
  • iBio, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 160 %, a 79.7% increase year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 160 +71.1 +79.7% Mar 31, 2024
Q4 2023 185 +118 +176% Dec 31, 2023
Q3 2023 170 +119 +233% Sep 30, 2023
Q2 2023 122 +76.8 +170% Jun 30, 2023
Q1 2023 89.2 +48.7 +120% Mar 31, 2023
Q4 2022 67.2 +28.8 +74.9% Dec 31, 2022
Q3 2022 51.1 +13.7 +36.6% Sep 30, 2022
Q2 2022 45.2 +7.39 +19.5% Jun 30, 2022
Q1 2022 40.5 -2.73 -6.32% Mar 31, 2022
Q4 2021 38.4 -22.6 -37% Dec 31, 2021
Q3 2021 37.4 -69.6 -65.1% Sep 30, 2021
Q2 2021 37.8 -220 -85.3% Jun 30, 2021
Q1 2021 43.2 -3.48 K -98.8% Mar 31, 2021
Q4 2020 61 -1.83 K -96.8% Dec 31, 2020
Q3 2020 107 -558 -83.9% Sep 30, 2020
Q2 2020 258 -88.7 -25.6% Jun 30, 2020
Q1 2020 3.52 K +3.28 K +1348% Mar 31, 2020
Q4 2019 1.89 K +1.64 K +644% Dec 31, 2019
Q3 2019 665 +397 +147% Sep 30, 2019
Q2 2019 346 +32.8 +10.5% Jun 30, 2019
Q1 2019 243 -155 -38.9% Mar 31, 2019
Q4 2018 254 -49 -16.2% Dec 31, 2018
Q3 2018 269 -68.6 -20.3% Sep 30, 2018
Q2 2018 314 -16 -4.85% Jun 30, 2018
Q1 2018 398 +76.9 +23.9% Mar 31, 2018
Q4 2017 303 -68.9 -18.5% Dec 31, 2017
Q3 2017 337 +83.9 +33.1% Sep 30, 2017
Q2 2017 330 +167 +103% Jun 30, 2017
Q1 2017 321 +235 +272% Mar 31, 2017
Q4 2016 372 +358 +2489% Dec 31, 2016
Q3 2016 254 +240 +1762% Sep 30, 2016
Q2 2016 163 +148 +1038% Jun 30, 2016
Q1 2016 86.4 +72.5 +523% Mar 31, 2016
Q4 2015 14.4 Dec 31, 2015
Q3 2015 13.6 Sep 30, 2015
Q2 2015 14.3 Jun 30, 2015
Q1 2015 13.9 Mar 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.